Sign In | Register
Navigation:
Home
Programs
United States Department of Health and Human Services (HHS)
Cardiovascular Diseases Research
United States Department of Health and Human Services (HHS)

93.837 Cardiovascular Diseases Research

Uniform Guidance

Uniform Guidance Interim Final Rule - HHS

Findings Library

2023 Compliance Supplement

Please sign in to view this information. Part 3 - Compliance Requirements

Please sign in to view this information. Part 3 - Compliance Requirements (redline version)

2022 Compliance Supplement

Please sign in to view this information. Part 3 - Compliance Requirements

Please sign in to view this information. Part 3 - Compliance Requirements (redline version)

Federal Regulations

45 cfr 75 - uniform administrative requirements, cost principles, and audit requirements for hhs awards

Other

award conditions and information for nih grants

general funding guidelines

hhs.gov - grants policies & regulations

nih grants policy statement

CFDA Historical Index



2021

Action/Change Type: publish
Change Description: Cardiovascular Diseases Research


2020

Action/Change Type: publish
Change Description: Cardiovascular Diseases Research


2019

Action/Change Type: publish
Change Description: Cardiovascular Diseases Research

Program Objective

To foster heart and vascular research in the basic, translational, clinical and population sciences, and to foster training to build talented young investigators in these areas, funded through competitive research training grants. Small Business Innovation Research (SBIR) program: To stimulate technological innovation; use small business to meet Federal research and development needs; foster and encourage participation in innovation and entrepreneurship by socially and economically disadvantaged persons; and increase private-sector commercialization of innovations derived from Federal research and development funding. Small Business Technology Transfer (STTR) program: To stimulate technological innovation; foster technology transfer through cooperative R&D between small businesses and research institutions, and increase private sector commercialization of innovations derived from federal R&D.

Reported Expenditures

Fiscal Year End 2024 2023 2022
Total reported expenditures $0 $1,516,704,819 $1,837,314,076
Expenditures audited as a major program $0 $1,125,033,250 $1,159,708,324
Expenditures with audit findings $0 $270,915,190 $124,418,544
R&D Expenditures $0 $0 $0

Expenditure Metrics

Fiscal Year End 2024 2023 2022
Number of award recipients 0 4,174 5,455
Number of awards audited 0 2,811 3,519
Number of awards with findings 0 287 201
Percent of audited programs with findings 0% 10% 6%
Percent of awards reported as R&D 0% 0% 0%

Note: This information has been compiled from data collection form submissions to the Federal Audit Clearinghouse, Harvester.census.gov.

Note 2: This information is updated periodically and may not include recent data collection form submissions.

Contact Information

Dana A. Phares 6701 Rockledge Drive, Room 7176, Bethesda, Maryland 20892 Email: pharesda@nhlbi.nih.gov Phone: 301-435-0314


Legal Disclaimer

This information is accumulated from various sources, including but not limited to, beta.sam.gov, cfda.gov, whitehouse.gov and the web sites from various government agencies. The accuracy and completeness of this information has not been verified. Accordingly, we do provide any warranties over the accuracy or completeness of this information. By using this site, you agree to accept all responsibility for inaccurate or incomplete information contained herein.

🔍 Program by CFDA#
★ Recently Viewed Programs

93.837 Cardiovascular Diseases Research

Jobs/Classifieds

Post your job openings here.


Post a Job